Using NIRS to Evaluate Splanchnic Oxygenation During Blood Transfusion in Preterm Infant
NCT ID: NCT06663085
Last Updated: 2024-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
42 participants
INTERVENTIONAL
2024-10-30
2025-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Splanchnic Tissue Oxygenation During Enteral Feedings in Anemic Premature Infants at Risk for Necrotizing Enterocolitis
NCT01735578
Significance of Ultrasound Combined with Near-Infrared Spectroscopy in Monitoring Transfusion-Associated Intestinal Injury in Extremely Preterm Infants: a Study Protocol for a Prospective, Observational Study
NCT06857812
Splanchnic Oxygenation Response to Feeds in Preterm Neonates: Effect of Red Blood Cell Transfusion
NCT03643458
Comparison of Regional Splanchnic Tissue Oxygenation Measured by NIRS in Preterm Babies Fed Bolus Versus Continuous Feeding
NCT02072109
Combining Restrictive Guidelines and a NIRS SCORE to Decrease RBC Transfusions
NCT02535208
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group not received enteral feeding
control group not received enteral feeding during blood transfusion
No interventions assigned to this group
intervention group received enteral feeding
intervention group still received enteral feeding during blood transfusion
Enteral feeding
intervention group received enteral feeding breastmilk during transfusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enteral feeding
intervention group received enteral feeding breastmilk during transfusion
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Planned to receive blood transfusion
* Had received minimum 25 ml/kg/day enteral feeding
* in stable condition
Exclusion Criteria
* Infant with suspected/confirmed genetic anomalies
* Parents or family did not sign the informed consent
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gadjah Mada University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Leksmana Hidayatullah
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr Sardjito General Hospital
Yogyakarta, Special Region of Yogyakarta, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
leksmana hidayatullah, medical doctor
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KE/FK/1583/EC/2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.